CDH1 and breast cancer: A study relating Sgsm2 with breast cancer showed that silencing the expression of Sgsm2 protein resulted in a decreased expression of epithelial markers such as E-cadherin, β-catenin, and Paxillin, in addition to increased expression of markers such as Snail and Twist-1.